PT  - JOURNAL ARTICLE
AU  - Barisano, Giuseppe
AU  - Iv, Michael
AU  - ,
AU  - Choupan, Jeiran
AU  - Hayden-Gephart, Melanie
TI  - Cerebral perivascular spaces as predictors of dementia risk and accelerated brain atrophy
AID  - 10.1101/2024.04.25.24306324
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.25.24306324
4099  - http://medrxiv.org/content/early/2024/04/26/2024.04.25.24306324.short
4100  - http://medrxiv.org/content/early/2024/04/26/2024.04.25.24306324.full
AB  - Cerebral small vessel disease, an important risk factor for dementia, lacks robust, in vivo measurement methods. Perivascular spaces (PVS) on brain MRI are surrogates for small parenchymal blood vessels and their perivascular compartment, and may relate to brain health. We developed a novel, robust algorithm to automatically assess PVS count and size on MRI, and investigated their relationship with dementia risk and brain atrophy. We analyzed 46,478 clinical measurements of cognitive functioning and 20,845 brain MRI scans from 10,004 participants (71.1±9.7 years-old, 56.6% women). Fewer PVS and larger PVS diameter at baseline were associated with higher dementia risk and accelerated brain atrophy. Longitudinal trajectories of PVS markers were significantly different in non-demented individuals who converted to dementia compared with non-converters. In simulated placebo-controlled trials for treatments targeting cognitive decline, screening out participants less likely to develop dementia based on our PVS markers enhanced the power of the trial. These novel radiographic cerebrovascular markers may improve risk-stratification of individuals, potentially reducing cost and increasing throughput of clinical trials to combat dementia.Competing Interest StatementGiuseppe Barisano is listed as inventor on a patent application related to this work filed by Stanford University. The other authors declare that they have no competing interests.Funding StatementThe authors G.B. and M.H. are supported by a grant (U54CA261717 to Dr. Hayden-Gephart) from the National Institutes of Health (NIH), J.C. is supported by grants RF1MH123223, R01AG070825, and R01NS128486 from the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Only existing public datasets were used.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors